Viracta Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Viracta Therapeutics (VIRX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Viracta Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Viracta Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Viracta Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $410 | 721 | 0.57 |
| 2023-09-30 | $749 | 721 | 1.04 |
| 2023-06-30 | $1.0k | 721 | 1.41 |
| 2023-03-31 | $1.0k | 721 | 1.39 |
| 2022-12-31 | $1.0k | 721 | 1.39 |
| 2022-06-30 | $6.0k | 1.5k | 3.92 |
| 2022-03-31 | $102k | 21k | 4.76 |
| 2021-12-31 | $63k | 17k | 3.67 |